Results 61 to 70 of about 9,473,382 (158)

Pure Red Cell Aplasia in a Cat

, 2015
A 9-year-old male castrated American domestic shorthair cat was evaluated for lethargy, pallor, and anemia. A severe normocytic, normochromic, non-regenerative anemia with a mild leukocytosis and normal platelet count was identified. Testing was negative
Haber, Jennifer
core   +4 more sources

Recurrent Severe Anaemia: A Rare Presentation of Parvovirus B19 Infection [PDF]

Journal of Clinical and Diagnostic Research, 2014
Secondary pure red cell aplasia is usually seen in immunocompromised hosts or patients who have chronic haemolytic anaemia, which is caused by blood transfusion related transmission.
Santokh Singh, Gian Chand, Shiv Charan, Sahil Arora, Parampreet Singh   +4 more
doaj   +1 more source

PARVOVIRUS B19-INDUCED PERSISTENT PURE RED CELL APLASIA IN A CHILD WITH T-CELL IMMUNODEFICIENCY

, 2009
Persistent pure red cell aplasia can be a manifestation of parvovirus B19 infection in immunocompromised hosts. Failure of the humoral immune response to clear parvovirus B19 in such patients results in persistent pure red cell aplasia.
Turul, Tuba, Tavil, Betul, Gumruk, Fatma, Sanal, Oezden, Gurgey, Aytemiz, Yel, Leman   +5 more
core   +1 more source

Isoniazid-induced pure red cell aplasia in two siblings

, 1998
Pure red cell aplasia (PRCA) is a rare complication of treatment with isoniazid mainly observed in adults. We report two siblings who had anemia caused by PRCA during administration of isoniazid.
MARSEGLIA, GIAN LUIGI, LOCATELLI, FRANCO, Locatelli F., Marseglia G. L.   +3 more
core   +2 more sources

Clinico-Hematological Features in Pure Red Cell Aplasia Patients Diagnosed at Diagnostic & Research Laboratory, Hyderabad

Liaquat Medical Research Journal, 2020
Pure red-cell aplasia (PRCA) or erythroblastopenia is a rare type of anemia or disorder that can be either idiopathic or associated with certain autoimmune diseases and affect red blood cell (RBC) precursors1,2. The disease is often present at birth, and
Faheem Ahmed Memon
doaj  

A case report of soluble A antigen confounding the blood type in a haplo‐identical hematopoietic stem cell transplant patient with graft‐versus‐host disease

Transfusion, Volume 66, Issue 7, Page 1438-1443, July 2026.
Abstract Background ABO‐incompatible (ABOi) hematopoietic stem cell transplantation (HSCT) is often associated with ABO discrepancies post‐HSCT. Re‐emergence of the patient's original type post‐HSCT may signal graft loss, disease relapse, recent transfusion, or soluble ABO antigen.
Sheri Hugan, Nada Naiyer, Laura Cooling
wiley   +1 more source

RIFAMPICIN INDUCED PURE RED CELL APLASIA

Zdravniški Vestnik, 2008
BACKGROUND Pure red cell aplasia (PRCA) is a rare condition of severe anemia characterized by anabsence of erythroid precursor in the bone marrow, severe reticulocytopenia and normalplatelet and leukocyte count.
Marija Čeh
doaj  

International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences

Vox Sanguinis, Volume 121, Issue 7, Page 1065-1075, July 2026.
Abstract Background and Objectives Daratumumab, a therapeutic human anti‐CD38 monoclonal antibody, improves multiple myeloma outcomes but interferes with pre‐transfusion testing by binding CD38 on reagent red blood cells (RBCs), potentially masking clinically significant alloantibodies.
Arnaud Reggiani, Sofia Lejon Crottet, Sophie Waldvogel, Charlotte Engström, Serelina Coluzzi, Antonella Matteocci, Janis R. Hamilton, Levent Tufan Kumas, Karen M. K. de Vooght, Jill R. Storry, Jennylyn Flores, Núria Nogués, Carlos Cotorruelo, Molly Rutherford, Eveline B. Nilsen, Monika Pelc‐Kłopotowska, Jolanta Korzeniowska, Alessandra Baffa, Inna Sareneva, Nor Hafizah Ahmad, Katarzyna Szczudlo, Athif Rahman, Laser Sanal, Lise Jørgensen, Karolina Majewska Rochowiak, Monika Salwierz, Elisaveta Grancharova, Bojana Zivkovic, Jessica Alvarez, Mareike Riedl, Achim Knappik   +30 more
wiley   +1 more source

Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab

Haematologica, 2010
Background Pure red cell aplasia and moderate aplastic anemia are marrow failure states with an immune pathogenesis. Previously, we described short-term improvements in blood counts in two pilot studies treating moderate aplastic anemia (mAA) and pure ...
Elaine M. Sloand, Matthew J. Olnes, Barbara Weinstein, Colin Wu, Jaroslaw Maciejewski, Phillip Scheinberg, Neal S. Young   +6 more
doaj   +1 more source

Generation of CCR4/CD7 Bispecific CAR‐T Cells Resistant to Fratricide and Exhaustion

Advanced Science, Volume 13, Issue 35, 24 June 2026.
The applications of CAR T‐cell therapy in T‐cell malignancies face limitations such as fratricide, effector‐cell exhaustion, and antigen‐escape. Herein, we developed fratricide‐ and exhaustion‐resistant CAR‐T cells that targeted CCR4 and CD7 simultaneously, with optional EGFRt safety switch. Additionally, scRNA‐seq unveiled new molecular targets, which
Sile Li, Yuanxin Li, Asif Rashid, Hong Kee Tan, Shing Chan, Man Yan Hui, Wilson Yau Ki Chan, Kee See Lam, Yinping Liu, Wenwei Tu, Wing Leung   +10 more
wiley   +1 more source